Ultivue: Funding, Investors & Team (Oct 2026)
Ultivue is a biotechnology firm focusing on tissue imaging, diagnostics, and multiplexing. They create reagents that allow researchers to capture high-resolution microscopic images, aiding in the study of biology and medicine. Ultivue's products are tailored for fluorescent microscopy research and may have future applications in clinical diagnostics. Established in 2015, Ultivue is based in Cambridge, Massachusetts.
Ultivue has raised $53.3M across 2 funding rounds on record, the most recent an undisclosed round of $3.3M announced in Jul 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ultivue Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Ultivue Funding Rounds
Ultivue raised $50.0M in a Series D announced in Apr 2021.
3.3 years later, an undisclosed round of $3.3M was announced in Jul 2024.
Ultivue Founders and Leadership Team
Contact details for the Ultivue team: 1 of 2 have an email address on file.
Start 14-day free trial →Ultivue Funding Compared to Other Biotechnology Startups
Ultivue's latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ultivue in Biotechnology and Cambridge
Companies Similar to Ultivue
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Ultivue Funding FAQs
What does Ultivue do?
Ultivue is a biotechnology firm focusing on tissue imaging, diagnostics, and multiplexing. They create reagents that allow researchers to capture high-resolution microscopic images, aiding in the study of biology and medicine. Ultivue's products are tailored for fluorescent microscopy research and may have future applications in clinical diagnostics. Established in 2015, Ultivue is based in Cambridge, Massachusetts.
How much funding has Ultivue raised?
Ultivue has raised $53.3M across 2 rounds on record. The most recent is an undisclosed round of $3.3M announced in Jul 2024.
When did Ultivue last raise funding?
Ultivue's most recent funding round on record is an undisclosed round of $3.3M, announced in Jul 2024.
Who founded Ultivue?
FundedIQ lists Ralf Jungmann (Founder) at Ultivue.
Who is the CEO of Ultivue?
Jacques Corriveau is listed as CEO at Ultivue.
Where is Ultivue headquartered?
Ultivue is based in Cambridge, Massachusetts, United States.
How many employees does Ultivue have?
Ultivue is in the 51-100 employee band.
How does Ultivue's funding compare to other Biotechnology startups?
Ultivue's latest round of $3.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ultivue Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ultivue is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.